AI Article Synopsis

  • Allodynia, a condition affecting daily life and making migraines harder to treat, was studied in a trial involving 77 patients to evaluate the effectiveness of transcranial direct current stimulation (tDCS) for migraine prevention.
  • The study found that patients receiving active tDCS experienced significant reductions in migraine frequency, duration, and analgesic use compared to those receiving sham treatment, suggesting tDCS is a viable alternative therapy.
  • Response to tDCS was notably better in patients without allodynia, indicating that early intervention before the onset of allodynia may enhance treatment effectiveness.

Article Abstract

Objectives: Allodynia, the clinical marker of central sensitization, affects even simple daily living activities and increases the tendency for migraine to be more resistant to treatment and have a chronic course. Migraine that impairs quality of life can often be treated with variable pharmaceutical agents, but with various side effects. Transcranial direct current stimulation (tDCS) is a potential alternative treatment for migraine prophylaxis.

Materials And Methods: Seventy-seven patients diagnosed with migraine (48 with allodynia and 29 without allodynia) were included in the study. Randomly, 41 of the 77 patients received sham stimulation and 36 patients underwent three sessions of anodal left primary motor cortex stimulation for 2 mA, 20 min. Migraine attack characteristics (frequency, severity, and duration) and analgesic drug use were followed with headache diaries for one month after the stimulation.

Results: After tDCS, migraine attack frequency (p = 0.021), the number of headache days (p = 0.005), duration of attacks (p = 0.008), and symptomatic analgesic drug use (p = 0.007) decreased in patients receiving active tDCS, compared to the sham group. The therapeutic gain of tDCS was calculated as 44% (95% confidence interval [CI]: 22-60%) for headache days and 76% (95% CI: 55-86) for headache duration. Response to tDCS treatment was higher in patients without allodynia (60% vs. 24%; p = 0.028) and allodynia came out as an independent predictor of response to tDCS with logistic regression analysis. Side effects were rare and similar to the sham group.

Conclusions: tDCS is a safe, efficacious, and fast method for migraine prophylaxis. However, the administration of tDCS before allodynia occurs, that is, before central sensitization develops, will provide increased responsiveness to the treatment.

Significance: tDCS is more effective before the development of allodynia, but it also improves the quality of life even after the development of allodynia.

Download full-text PDF

Source
http://dx.doi.org/10.1111/ner.13409DOI Listing

Publication Analysis

Top Keywords

allodynia
9
tdcs
9
transcranial direct
8
direct current
8
current stimulation
8
central sensitization
8
quality life
8
side effects
8
migraine attack
8
analgesic drug
8

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!